BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cartesian Therapeutics\, Inc. readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Cartesian Therapeutics\, Inc.'s d
 rugs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06799247-3307@assetmemo.bio
DTSTAMP:20261121T005701Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:Descartes-08: Phase 3 readout est. (NCT06799247)
DESCRIPTION:Descartes-08\, phase 3\, Myasthenia Gravis.\nStudy: Investigati
 ng an mRNA CAR T-cell Therapy\, Known as Descartes-08\, as a Potential App
 roach to Treat Myasthenia Gravis\nEstimated primary completion: 30 Decembe
 r 2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout da
 te\, and it can move.\nDrug page: https://assetmemo.bio/drug/descartes-08#
 upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0679
 9247
URL:https://assetmemo.bio/drug/descartes-08#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07391605-3307@assetmemo.bio
DTSTAMP:20261121T005701Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Descartes-08: Phase 2 readout est. (NCT07391605)
DESCRIPTION:Descartes-08\, phase 2.\nStudy: Descartes-08 in Autoantibody My
 ositis\nEstimated primary completion: November 2027. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/descartes-08#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07391605
URL:https://assetmemo.bio/drug/descartes-08#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07089121-3307@assetmemo.bio
DTSTAMP:20261121T005701Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:Descartes-08: Phase 1/2 readout est. (NCT07089121)
DESCRIPTION:Descartes-08\, phase 1/2\, Myasthenia Gravis.\nStudy: Descartes
 -08 for Children\, Adolescents\, and Young Adults With Autoimmune Disorder
 s\nEstimated primary completion: December 2027. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/descartes-08#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT07089121
URL:https://assetmemo.bio/drug/descartes-08#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
